925 related articles for article (PubMed ID: 26272906)
1. MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORγ⁺ regulatory T cells.
Sefik E; Geva-Zatorsky N; Oh S; Konnikova L; Zemmour D; McGuire AM; Burzyn D; Ortiz-Lopez A; Lobera M; Yang J; Ghosh S; Earl A; Snapper SB; Jupp R; Kasper D; Mathis D; Benoist C
Science; 2015 Aug; 349(6251):993-7. PubMed ID: 26272906
[TBL] [Abstract][Full Text] [Related]
2. MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells.
Ohnmacht C; Park JH; Cording S; Wing JB; Atarashi K; Obata Y; Gaboriau-Routhiau V; Marques R; Dulauroy S; Fedoseeva M; Busslinger M; Cerf-Bensussan N; Boneca IG; Voehringer D; Hase K; Honda K; Sakaguchi S; Eberl G
Science; 2015 Aug; 349(6251):989-93. PubMed ID: 26160380
[TBL] [Abstract][Full Text] [Related]
3. Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
Lima SF; Gogokhia L; Viladomiu M; Chou L; Putzel G; Jin WB; Pires S; Guo CJ; Gerardin Y; Crawford CV; Jacob V; Scherl E; Brown SE; Hambor J; Longman RS
Gastroenterology; 2022 Jan; 162(1):166-178. PubMed ID: 34606847
[TBL] [Abstract][Full Text] [Related]
4. Increased CD4
Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ
World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423
[TBL] [Abstract][Full Text] [Related]
5. MICROBIOME. Microbiota RORgulates intestinal suppressor T cells.
Hegazy AN; Powrie F
Science; 2015 Aug; 349(6251):929-30. PubMed ID: 26315421
[No Abstract] [Full Text] [Related]
6. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
[TBL] [Abstract][Full Text] [Related]
7. Antigen-Specific Development of Mucosal Foxp3+RORγt+ T Cells from Regulatory T Cell Precursors.
Solomon BD; Hsieh CS
J Immunol; 2016 Nov; 197(9):3512-3519. PubMed ID: 27671109
[TBL] [Abstract][Full Text] [Related]
8. CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease.
Sarrabayrouse G; Bossard C; Chauvin JM; Jarry A; Meurette G; Quévrain E; Bridonneau C; Preisser L; Asehnoune K; Labarrière N; Altare F; Sokol H; Jotereau F
PLoS Biol; 2014 Apr; 12(4):e1001833. PubMed ID: 24714093
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immunology: Microbiota-induced T cells block allergic inflammation.
Bordon Y
Nat Rev Immunol; 2015 Aug; 15(8):468. PubMed ID: 26205581
[No Abstract] [Full Text] [Related]
10. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.
Yang BH; Hagemann S; Mamareli P; Lauer U; Hoffmann U; Beckstette M; Föhse L; Prinz I; Pezoldt J; Suerbaum S; Sparwasser T; Hamann A; Floess S; Huehn J; Lochner M
Mucosal Immunol; 2016 Mar; 9(2):444-57. PubMed ID: 26307665
[TBL] [Abstract][Full Text] [Related]
11. T-helper 17 and interleukin-17-producing lymphoid tissue inducer-like cells make different contributions to colitis in mice.
Ono Y; Kanai T; Sujino T; Nemoto Y; Kanai Y; Mikami Y; Hayashi A; Matsumoto A; Takaishi H; Ogata H; Matsuoka K; Hisamatsu T; Watanabe M; Hibi T
Gastroenterology; 2012 Nov; 143(5):1288-1297. PubMed ID: 22850180
[TBL] [Abstract][Full Text] [Related]
12. Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer.
Blatner NR; Mulcahy MF; Dennis KL; Scholtens D; Bentrem DJ; Phillips JD; Ham S; Sandall BP; Khan MW; Mahvi DM; Halverson AL; Stryker SJ; Boller AM; Singal A; Sneed RK; Sarraj B; Ansari MJ; Oft M; Iwakura Y; Zhou L; Bonertz A; Beckhove P; Gounari F; Khazaie K
Sci Transl Med; 2012 Dec; 4(164):164ra159. PubMed ID: 23241743
[TBL] [Abstract][Full Text] [Related]
13. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.
Hovhannisyan Z; Treatman J; Littman DR; Mayer L
Gastroenterology; 2011 Mar; 140(3):957-65. PubMed ID: 21147109
[TBL] [Abstract][Full Text] [Related]
14. Induction of Treg cells in the mouse colonic mucosa: a central mechanism to maintain host-microbiota homeostasis.
Tanoue T; Honda K
Semin Immunol; 2012 Feb; 24(1):50-7. PubMed ID: 22172550
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D Regulates the Microbiota to Control the Numbers of RORγt/FoxP3+ Regulatory T Cells in the Colon.
Cantorna MT; Lin YD; Arora J; Bora S; Tian Y; Nichols RG; Patterson AD
Front Immunol; 2019; 10():1772. PubMed ID: 31417552
[TBL] [Abstract][Full Text] [Related]
16. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota.
Round JL; Lee SM; Li J; Tran G; Jabri B; Chatila TA; Mazmanian SK
Science; 2011 May; 332(6032):974-7. PubMed ID: 21512004
[TBL] [Abstract][Full Text] [Related]
17. Heligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis.
Hang L; Blum AM; Setiawan T; Urban JP; Stoyanoff KM; Weinstock JV
J Immunol; 2013 Aug; 191(4):1927-34. PubMed ID: 23851695
[TBL] [Abstract][Full Text] [Related]
18. Induction of colonic regulatory T cells by indigenous Clostridium species.
Atarashi K; Tanoue T; Shima T; Imaoka A; Kuwahara T; Momose Y; Cheng G; Yamasaki S; Saito T; Ohba Y; Taniguchi T; Takeda K; Hori S; Ivanov II; Umesaki Y; Itoh K; Honda K
Science; 2011 Jan; 331(6015):337-41. PubMed ID: 21205640
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis.
Petito V; Graziani C; Lopetuso LR; Fossati M; Battaglia A; Arena V; Scannone D; Quaranta G; Quagliariello A; Del Chierico F; Putignani L; Masucci L; Sanguinetti M; Sgambato A; Gasbarrini A; Scaldaferri F
World J Gastroenterol; 2019 Mar; 25(12):1465-1477. PubMed ID: 30948910
[TBL] [Abstract][Full Text] [Related]
20. Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.
Yurchenko E; Shio MT; Huang TC; Da Silva Martins M; Szyf M; Levings MK; Olivier M; Piccirillo CA
PLoS One; 2012; 7(4):e35572. PubMed ID: 22545118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
